Analysis of the intracellular regulatory mechanism of bcl-2 related apoptosis.
Analysis of the intracellular regulatory mechanism of bcl-2 related apoptosis.
批准号:
07670238
负责人:
TANAKA Shigeki
金额:
$1.28万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1996
中文摘要
点击翻译按钮获取中文摘要
英文摘要
1. Anti-apoptotic effect and the expression of p26 bcl-2 We have investigated the anti-apoptotic effect of bcl-2 proto-oncogene using bcl-2 transfectants (bcl-2 was introduced to CCRF-CEM,MBC-1, WEHI-164,2AD4) with various factor inducible apoptosis. The cells expressing a large amount of p26 bcl-2 showed higher viability when cell death was induced with H_2O_2, Dexamethasone and anti-lgM.Especially, bcl-2 has a stronger anti-apoptotic effect in the death induced with H_2O_2 than in the death induced with others. There was no significant correlation between the anti-apoptotic effect and the expression of p26 bcl-2 in the cell death induced with A23187, TNF-alpha. 2. Intarcellular events in the early phase of apoptosis and the expression of p26 bcl-2 The studies of intracellular reactive oxygen species and mitochondrial transmembrane potential of MBC-1 cells using fluorescence dye revealed no significant difference between bcl-2 transfectants and controls when cell death was induced with H_2O_2. Whereas p26 bcl-2 has significant anti-apoptotic effect in MBC-1 cells undergoing apoptosis with H_2O_2. When the transfectants of CEM-C7 cells were treated with H_2O_2, reactive oxygen species were markedly reduced but not correlate with the level of p26 bcl-2. Both intracellular reactive oxygen species and mitochondrial transmembrane potential showed no significant change in CEM,MBC-1 cells when cell death was induced with dexamethasone and anti-lgM respectively. These results suggest the anti-apoptotic effect of p26 bcl-2 has some direct relation to reactive oxygen species in early phase of apoptosis.
期刊论文(18)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Yoshihiro Komada: "Fas Receptor (CD95)-mediated apoptosis is induced in leukemic cells entering G1B compartment of the cell cycle." Blood. 86. 3848-3860 (1995)
Yoshihiro Komada:“Fas 受体 (CD95) 介导的细胞凋亡在进入细胞周期 G1B 区室的白血病细胞中被诱导。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Shinichi Kitada: "Reversal of chemoresistance of lymphoma cell by antisense-mediated reduction of bcl-2 gene expression" Antisense Research and Developmment. 4. 71-79 (1994)
Shinichi Kitada:“通过反义介导的 bcl-2 基因表达减少来逆转淋巴瘤细胞的化疗耐药性”反义研究与开发。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Shinichi Kitada: "Reversal of chemoresistance of lymphoma cells by antisense-mediatedreduction of bcl-2 gene expression." Antisense Research and Devlopment. 4. 71-79 (1994)
Shinichi Kitada:“通过反义介导的 bcl-2 基因表达减少来逆转淋巴瘤细胞的化疗耐药性。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yoshihiro Komada et al.: "Fas Receptor (CD95) -mediated cytotoxicity is responsible for the apoptotic cell death of leukemic cells induced by interleukin-2-activated T cells." British Journal of Haematology. 96. 147-157 (1997)
Yoshihiro Komada 等人:“Fas 受体 (CD95) 介导的细胞毒性是白细胞介素 2 激活的 T 细胞诱导白血病细胞凋亡的原因。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yoshihiro Komada: "Apoptotic cell death induced by anti-lgM antibody and phorbol esters is inhibited by Interleukin-4 in human B lymphoma cell line MBC-1." Cellular Immunology. 159. 280-293 (1994)
Yoshihiro Komada:“在人 B 淋巴瘤细胞系 MBC-1 中,Interleukin-4 可抑制抗 IgM 抗体和佛波酯诱导的细胞凋亡。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 18 条
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: